Glaxosmithkline reported 1.96B in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.13B 73M
Amgen AMGN:US $ 1.33B 99M
AstraZeneca AZN:LN 3.27B 209M
Aurora Cannabis Inc ACB:CN 43.17M 3.69M
Bristol Myers Squibb BMY:US $ 1.78B 46M
Canopy Growth Corp WEED:CN C$ 108.85M 1.48M
Catalent CTLT:US $ 207M 21M
Corcept Therapeutics CORT:US $ 37.81M 264K
Eli Lilly And LLY:US $ 1.63B 67.2M
Endo International Ordinary Shares ENDP:US 180.83M 45.18M
Glaxosmithkline GSK:US 1.96B 726M
GlaxoSmithKline GSK:LN 1.96B 726M
Horizon Pharma HZNP:US 398.22M 25.49M
JAZZ PHA JAZZ:US 325.67M 16.86M
Johnson & Johnson JNJ:US $ 6.23B 288M
Lannett LCI:US $ 17.57M 1.22M
Merk MRK:US $ 2.42B 118M
Novartis NOVN:VX 3.59B 91M
Pacira Pharmaceuticals PCRX:US $ 65M 743K
Perrigo Ordinary Shares PRGO:US 338.1M 55.8M
Pfizer PFE:US $ 3.2B 506M
Phibro Animal Health PAHC:US $ 52.43M 4.05M
Prestige Brands PBH:US $ 66.66M 1.92M
Supernus Pharmaceuticals SUPN:US $ 100.48M 10.02M
Takeda 4502:JP 231.48B 8.05B
Teva Pharmaceutical TEVA:IT 849M 30M
Valeant Pharmaceuticals VRX:CN C$ 622M 58M
Zoetis ZTS:US $ 529M 64M